Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-BTLA, JS004 Vector   (CAT#: GTVCR-WQ1644MR)

This product GTVCR-WQ1644MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting BTLA. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Chimeric
RefSeq NM_001085357.2
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 151888
UniProt ID Q7Z6A9
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-BTLA, JS004 Vector (GTVCR-WQ1644MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1163MR IVTScrip™ pT7-VEE-mRNA-Anti-TNF, ENIA11 Vector Vector ENIA11
GTVCR-WQ250MR IVTScrip™ pT7-VEE-mRNA-Anti-Aβ15-42, ACC-001 Vector Vector ACC-001
GTVCR-WQ2602MR IVTScrip™ pT7-VEE-mRNA-Anti-NGcGM3, UNII-52G405U1E5 Vector Vector UNII-52G405U1E5
GTVCR-WQ1246MR IVTScrip™ pSP6-VEE-mRNA-Anti-EGFR, GA201 Vector Vector GA201
GTVCR-WQ2477MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD70, SGN-70 Vector Vector SGN-70
GTVCR-WQ1214MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD19, FMC63 scFv-G4h-28-F9Z-TpERt CAR Vector Vector FMC63 scFv-G4h-28-F9Z-TpERt CAR
GTVCR-WQ2454MR IVTScrip™ pSP6-VEE-mRNA-Anti-DPEP3, SC-003 mAb Vector Vector SC-003 mAb
GTVCR-WQ2303MR IVTScrip™ pT7-VEE-mRNA-Anti-MSTN, REGN-1033 Vector Vector REGN-1033
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.